Buswell Biomedical End of Year Letter

Hello Buswell Biomedical Community,

As we wrap up 2023, I'm thrilled to share the incredible journey we've had together. Shifting to this newsletter format boosted our online visibility by almost 300%, a major win for us!

Let's take a moment to celebrate the milestones we reached this year:

• Stella Labs Cohort: We kicked off the year by being part of the Stella Labs Cohort in Fall 2022. Our pitch in early 2023 marked a key moment in our journey.

• Finalist Recognitions: Being a finalist at the San Diego Angel conference and presenting at Invest Midwest in the spring were true honors for Buswell Biomedical.

• 
  

• TECH STL Health Tech Week: Our dedicated table at TECH STL's Health Tech event allowed us to showcase our passion and dedication to making a difference.

• Women's Fast Pitch Midwest: Making it to the finals was an incredible achievement. Thank you to everyone who cheered us on virtually!

• Patent Success: Securing a patent for our entire device in late summer was a significant milestone, reinforcing our commitment to innovation.

• Partnership with ALIEN TT: The end of the year brought a promising partnership with ALIEN TT, setting the stage for exciting collaborations ahead.

Although we didn't quite finish our prototype, Jermaine Sims completed the design, and we're gearing up to have the mechanical prototype ready in the first quarter of 2024.

In the face of challenges, our spirit remains hopeful and optimistic. We've had the pleasure of featuring on various business podcasts, and our goal for the upcoming year is to amplify our presence in this space.

As we eagerly anticipate 2024, we want to express our gratitude for your unwavering support. Together, we're excited about the endless possibilities that lie ahead for Buswell Biomedical.

Cheers to a fantastic 2023, and here's to an even more remarkable 2024!

Warm regards,

Sheila Buswell

Buswell Biomedical Team